期刊文献+

阿尔茨海默病的免疫异常机制及免疫指标 被引量:3

下载PDF
导出
摘要 阿尔茨海默病(Alzhemier's disease,AD)是一种多见于老年人的渐进性神经系统变性疾病。通常病情呈进行性加重,患者逐渐丧失独立生活能力,最后死于并发症。来自实验及临床的研究资料提示动物模型及患者的体液免疫反应和细胞免疫反应功能异常。AD患者与健康同龄老人血清和脑脊液中T细胞、B细胞及细胞因子等出现明显差异。AD发生的免疫异常机制也成为目前研究的热点。
作者 王延辉
出处 《吉林医学》 CAS 2009年第10期870-871,共2页 Jilin Medical Journal
  • 相关文献

参考文献13

  • 1Oddo S,Billings L,Kesslak JP,et al.A beta immunotherapy leads to clearance of early,but not late,hyperphosphorylatedtau aggregates via the proteasome[J].Neuron,2004,43(3):321.
  • 2Weller RO,Massey A,Kuo YM,et al.Cerebral amyloid angiopathy:accumulation of a beta in interstitial fluid drainage pathways in Alzheimer's disease[J].Ann NY Acad Sci,2000,903(1):110.
  • 3Suo Z,Tan J,Placzek A,et al.Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells:the roles of cytokines and CD40[J].Brain Res,1998,807(1-2):110.
  • 4彭丹涛,许贤豪.β淀粉样变与阿尔茨海默病[J].中华老年心脑血管病杂志,2005,7(6):430-432. 被引量:2
  • 5Blennew K.Cerebroepinal fluid protein biomarkers for Alzheimer's disease[J].Neuroboid Aging,2004,25(4):685.
  • 6Pametti L,Lanari A,Silvestrelli G,et al.Diagnosing prodromal Alzheimer's disease:role of CSF biochemical markers[J].Mech Ageing Dev,2006,127(1):129.
  • 7Hansson O,Zetterberg H,Buchhave P,et al.Association between CSF biomarkers and impairment:a follow-up[J].Lancet Neurol,2006,5(1):228.
  • 8Levey A,Lah J,Goldstein F,et al.Mild cognitive impairment:an opportunity to identify patients at high risk for progression to Alzheimer's disease[J].Clin Ther,2006,28(4):991.
  • 9Richartz E,Stransky E,Ratra A,et al.Decline of immune responsiveness:a pathogenetic factor in Alzheimer's disease?[J].J Psychiatric Res,2005,39 (5):535.
  • 10Monsonego A,Zota V,karni A,et al.Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease[J].J Clin Invest,2003,112(3):415.

二级参考文献14

  • 1盛树力.阿尔茨海默病[M].北京.科学技术文献出版社,1999,83-247.
  • 2Matsubara E, Shoji M, Abe K, et al. Vascular amyloidosis in neurodegenerative condition[J]. Drugs News Perspect,2002,15:439-444.
  • 3Shinkai Y, Yoshimura M, Ito Y, et al. Amyloid beta-protein 1 - 40 and 1 - 42 in the soluble fraction of extra- and intracranial blood vessels[J]. Ann Neurol, 1995,38,421-428.
  • 4Khalil Z, Chen H, Helme RD. Mechanisms underlying the vascular activity of beta-amyloid protein fragment at the level of skin microvasculature[J]. Brain Res, 1996,736:206.
  • 5Greenberg SM. Cerebral amyloid angiopathy [ J ]. Neurology, 1998,51 : 690-694.
  • 6Hendriks L, Van Duijin CM,Cras P, et al. Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the betaamyloid precursor protein gene [ J ]. Nature Genet, 1992,1 : 218-221.
  • 7Nilsberth C, Forsell C, Axelman K, et al. A novel APP mutation -the Arctic mutation-causing Alzheimer' s disease with vascular symptoms[J]. Soc Neurosci, 1999,25 : 120-124.
  • 8Natte R, Mattt MLC, Haan J, et al. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibfillary tangles[ J]. Ann Neurol, 2001,50: 765-772.
  • 9Grabowski TG, Cho HS, Vonsattal JP, et al. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy[J]. Ann Neurol,2001,49:697-705.
  • 10Holton JL, Ghiso J, Lashley T, et al. Regional distribution of amyloidal Bri deposition and its association with neurofibrillary degeneration in familial British dementia[J]. Am J Pathol,2001,158:515-526.

共引文献1

同被引文献30

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部